AET - Aetna Inc.

NYSE American - NYSE American Delayed Price. Currency in USD
0.0000
0.0000 (0.33%)
As of 4:02PM EST. Market open.
Stock chart is not supported by your current browser
Previous Close0.0000
Open212.5700
Bid0.00 x 800
Ask0.00 x 800
Day's Range211.7900 - 213.3600
52 Week Range166.8900 - 213.3600
Volume10,740,557
Avg. Volume2,807,873
Market Cap0
Beta (3Y Monthly)0.89
PE Ratio (TTM)0.00
EPS (TTM)11.12
Earnings DateJan 28, 2019 - Feb 1, 2019
Forward Dividend & Yield2.00 (0.97%)
Ex-Dividend Date2018-10-23
1y Target Est208.31
Trade prices are not sourced from all markets
  • Pass it on: CVS CEO says the learning should never stop
    Associated Pressyesterday

    Pass it on: CVS CEO says the learning should never stop

    Larry Merlo has learned a few things during nearly eight years as CEO of one of the nation's biggest drugstore chains — including that you shouldn't ever stop learning. CVS Health Corp. is polishing off a $69-billion acquisition of the health insurer Aetna. The company, which also manages pharmacy benefits, is focusing more on providing in-store health care services and telemedicine, as retailers face pressing competition for product sales from the online giant Amazon.com.

  • Insider Q&A: CVS Health CEO seeks bigger role in your care
    Associated Pressyesterday

    Insider Q&A: CVS Health CEO seeks bigger role in your care

    CVS Health CEO Larry Merlo wants customers to think about more than prescriptions and shampoo when they visit his company's drugstores. CVS has largely finished its $69 billion acquisition of the insurer Aetna, part of the company's broader effort to expand its health care offerings. Merlo spoke recently with The Associated Press.

  • Is Walgreens Boots Alliance a Buy?
    Motley Foolyesterday

    Is Walgreens Boots Alliance a Buy?

    The pharmacy giant has the wind at its back right now. But will the winds change?

  • CVS defends settlement that allowed Aetna merger as judge assesses
    Reuters3 days ago

    CVS defends settlement that allowed Aetna merger as judge assesses

    CVS Health Corp (CVS.N) defended on Friday an agreement with the U.S. Justice Department which allowed it to purchase health insurer Aetna for $69 billion, a settlement that a federal judge is still assessing. The Justice Department approved the merger of CVS, a U.S. pharmacy chain and benefits manager, and Aetna in October on condition that Aetna sell its Medicare prescription drug plan business to WellCare Health Plans Inc (WCG.N). Now, the Justice Department and companies have found themselves in the unusual position of defending their antitrust settlement to a skeptical federal judge.

  • CVS defends settlement that allowed Aetna merger as judge assesses
    Reuters3 days ago

    CVS defends settlement that allowed Aetna merger as judge assesses

    The Justice Department approved the merger of CVS, a U.S. pharmacy chain and benefits manager, and Aetna in October on condition that Aetna sell its Medicare prescription drug plan business to WellCare Health Plans Inc . Now, the Justice Department and companies have found themselves in the unusual position of defending their antitrust settlement to a skeptical federal judge. In its brief, filed on Friday, CVS said that the deal had been extensively reviewed and urged the judge to allow the companies to continue integrating while he examines the settlement reached with the government.

  • Motley Fool3 days ago

    Ask a Fool: What Should I Do if a Company Whose Stock I Own Gets Acquired?

    The right answer depends on the details of the acquisition.

  • CNBC3 days ago

    Goldman downgrades Walgreens' stock to rare 'sell,' shares fall

    Goldman analyst Robert Jones said he doesn't think Walgreens' numerous partnerships with other companies will help offset declines in its core retail pharmacy business. He downgraded Walgreens to "sell" from "hold" Friday.

  • CNBC3 days ago

    Goldman downgrades Walgreens' stock to rare 'sell,' shares fall

    Goldman analyst Robert Jones said he doesn't think Walgreens' numerous partnerships with other companies will help offset declines in its core retail pharmacy business. He downgraded Walgreens to "sell" ...

  • Asian shares fall on poor Chinese economic data
    Associated Press4 days ago

    Asian shares fall on poor Chinese economic data

    SINGAPORE (AP) — Asian markets tumbled on Friday after China reported weaker-than-expected economic data, stirring up worries about the state of the world's second largest economy.

  • Associated Press4 days ago

    CVS and Delta fall while Aflac and General Electric jump

    Stocks that moved substantially or traded heavily Thursday: CVS Health Corp., down $1.13 to $73.37 The New York Post reported that a judge might bar CVS from integrating its business with health insurer ...

  • TheStreet.com4 days ago

    U.S. Stocks Close Mixed After Late Rally; GE, P&G Gain

    The Dow Jones Industrial Average rose Thursday as Wall Street expressed optimism over U.S. and China trade talks. said Thursday it would invest $1 billion to build a new campus in Austin, Texas. Stocks traded mixed on Thursday, Dec. 13, as Wall Street monitored trade developments between the U.S. and China, the world's two largest economies.

  • Motley Fool4 days ago

    Top 10 Healthcare Stories of 2018

    New drugs, trial flops, M&A, and a little bit of everything else that happened in healthcare in 2018.

  • TheStreet.com4 days ago

    Apple, Adobe, Huawei, CVS and Boy Scouts - 5 Things You Must Know

    U.S. stock futures were mixed on Thursday, Dec. 13, and shares in Asia closed higher as trade tensions eased between the U.S. and China, the world's two largest economies. Wall Street finished higher on Wednesday, Dec. 12, as investors cheered progress in U.S.-China trade talks and after a report said China was planning a new program that promised greater access for foreign companies. The Wall Street Journal reported Wednesday that China was drafting a replacement for Made in China 2025 - President Xi's blueprint to make the country a leader in high-tech industries - which would play down China's bid to dominate manufacturing and be more open to participation by foreign companies.

  • CNBC5 days ago

    In acquiring Aetna, CVS embarks on another pivotal moment in its 55-year history

    CVS Health acquired health insurance giant Aetna for about $70 billion. CVS has bought other pharmacies to build its footrprint, as well as pharmacy benefit manager Caremark and walk-in health clinic MinuteClinic. It's buying a health insurer to prove it.

  • TheStreet.com6 days ago

    Expect Less M&A in 2019 as Big Year Comes to a Close

    To start 2018, many on Wall Street were predicting a great year for stocks, as Donald Trump's tax plan was expected to produce elevated mergers and acquisitions activity. The deal activity has certainly been a part of the 2018 story, but the trend could slow down in 2019, said analysts from Goldman Sachs. Deal announcements are expected to increase 20% year over year in 2018, according to a note from Goldman that was released Tuesday.

  • CNBC6 days ago

    Stocks making the biggest moves premarket: DSW, F, GM, CVS, PFE & more

    These are the stocks posting the largest moves before the bell.

  • The Wall Street Journal11 days ago

    [$$] Walgreens Launches Next-Day Prescription Home Delivery With FedEx

    Walgreens Boots Alliance Inc. has teamed up with FedEx Corp. to launch a nationwide next-day prescription home-delivery service as the drugstore chain works to stave off competition from Amazon.com Inc. and other rivals. Under the delivery service called Walgreens Express, patients enrolled in text alerts will receive text notification when qualifying prescriptions are ready, Walgreens said Thursday. For a $4.99 fee, patients can have their prescriptions delivered by FedEx to their home as early as the next day.

  • Walgreens expands prescription delivery program nationwide
    Associated Press11 days ago

    Walgreens expands prescription delivery program nationwide

    Walgreens is joining rival drugstore chain CVS Health in expanding home deliveries for prescriptions nationwide, as stores continue adjusting to a retail world made more consumer-friendly by online competition. Walgreens said Thursday it will partner with FedEx to deliver prescriptions as soon as the next day for a $4.99 fee, and it also is providing same-day deliveries in several cities including New York, Chicago and Dallas. Walgreens and FedEx Corp. began a partnership last year where the drugstore chain started offering package drop-off and pick-up services at several thousand stores.

  • CNBC11 days ago

    Stocks making the biggest moves premarket: FB, GOOG, SIG, CVS, THO & more

    These are the stocks posting the largest moves before the bell.

  • CVS Hears Trump, But Don't Count on Lower Drug Prices
    Bloomberg12 days ago

    CVS Hears Trump, But Don't Count on Lower Drug Prices

    The company announced a new pricing model for its pharmacy benefit management services Wednesday morning. The White House has been an active critic of PBMs, which negotiate drug discounts on behalf of employers and health plans, arguing that they have distorted the drug-pricing system. Drugmakers pay rebates than can amount to more than 50 percent of a drug’s sticker price to secure favorable coverage on PBM drug lists, and critics contend that firms like CVS keep an excessive slice of those undisclosed payments.

  • CNBC12 days ago

    CVS CEO has a fix for those mile-long receipts — here's how it works

    "There's a way to get all of that digitally on your phone," along with the coupons and extra bucks rewards, CVS CEO Larry Merlo tells CNBC's Bertha Coombs.

  • TheStreet.com12 days ago

    CVS Health to Roll Out New Drug Pricing Model

    The new model will allow CVS Caremark to pass through 100% of drug rebates to its health plan clients.

  • CVS offers 'guaranteed net cost' for pharmacy benefit clients
    Reuters12 days ago

    CVS offers 'guaranteed net cost' for pharmacy benefit clients

    The "guaranteed net cost" option could also deflect growing criticism that pharmacy benefit managers (PBMs) reap gains off the widening gap between pharmaceutical list prices and their lower net cost after hefty rebates paid by drugmakers to secure coverage and access to their products. President Donald Trump, who has promised lower prescription drug costs for U.S. consumers, earlier this year singled out industry "middlemen", such as PBMs and insurers, and the common practice of drugmakers offering rebates to them.